Understanding how synthetic RNA is recognised in cells has proven essential in developing effective vaccines. Typically, the mRNA codes for a known viral antigen.

Yet what is particularly striking is that both are mRNA vaccines, mRNA being short for “synthetic messenger RNA.” Understanding why these are so novel requires some background on the history ...

New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV.

This research is vital for our defense against potential biological threats — including accidents and deliberate attacks.

The approval of messenger RNA (mRNA) based COVID-19 vaccines marked a pivotal scientific milestone, establishing mRNA as an innovative drug modality with immense therapeutic potential. However, due to ...

Messenger RNA instructs cells on which proteins to make. In theory, synthetic mRNA allows scientists to manipulate this process to create any protein, including those necessary for vaccination.

Thanks to Moderna’s and Pfizer’s highly effective COVID-19 vaccines, “messenger RNA” has become a household term — and a source of misinformation and confusion. Although about two-thirds ...

With clinical vaccine trials for everything from HIV to Zika, messenger RNA could transform medicine—or widen health care inequalities.

Pfizer aims to have an Omicron-specific COVID-19 vaccine ready by March. Assuming it gains approval, it will mark the first revision of its messenger RNA (mRNA) vaccine Comirnaty since the initial ...

BioNTech, which partnered with Pfizer on a leading Covid-19 vaccine, is seeking to test that theory with synthetic messenger RNA — using it to coax the body into accepting a specific protein ...

Messenger RNA vaccines represent far more than a pandemic response tool, offering unprecedented opportunities to prevent and treat diseases that have plagued humanity for centuries.

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.